HEM Pharma Inc. · 타법인주식및출자증권취득결정
Decision to acquire shares and equity securities of another company
| 1. Issuer | Company name (nationality) | 주식회사 나이스헬스디바이스코퍼레이션 | CEO | 문성식 |
| Capital (KRW) | 3,300,000,000 | Relationship to Company | Subsidiary | |
| Total Shares Issued (shares) | 660,000 | Principal business | 기타금융투자업 | |
| -New shares acquired via 3-party allotment within last 6 months | No | |||
| 2. Acquisition Details | Shares acquired (shares) | 280,000 | ||
| Acquisition Amount (KRW) | 2,184,000,000 | |||
| Equity (KRW) | 6,244,874,634 | |||
| % of Equity | 34.97 | |||
| Large Enterprise | N/A | |||
| 3. Shares Held and Ownership Ratio After Acquisition | Shares Owned (shares) | 660,000 | ||
| Ownership (%) | 100 | |||
| 4. Acquisition Method | 현금취득 - 상환전환우선주 280,000주(구주취득) | |||
| 5. Purpose of Acquisition | 지배력 강화 및 사업 시너지 극대화를 위한 기업가치 제고 | |||
| 6. Planned Acquisition Date | 2026-12-09 | |||
| 7. Subject to material event report on asset acquisition | No | |||
| -Total assets at latest fiscal year-end (KRW) | 51,834,280,448 | Acquisition price / total assets (%) | 4.21 | |
| 8. Backdoor Listing | No | |||
| -Plans for third-party allotment capital increase etc. within 6 months (3) | No | |||
| 9. Issuer (other company) meets backdoor listing criteria | No | |||
| 10. Board Resolution Date (Decision Date) | 2026-11-20 | |||
| - Outside Directors Present | Present (persons) | 1 | ||
| Absent (persons) | 2 | |||
| - Auditor (Audit Committee Member) Attendance | Present | |||
| 11. Subject to KFTC Filing | N/A | |||
| 12. Put Option Agreements, etc. | No | |||
| - Contract Details | - | |||
| 13. Other Matters Relevant to Investment Decisions | 1. 상기 '2. 취득내역'의 자기자본은 당사의 최근사업연도말(2025. 12. 31) 한국채택국제회계기준(K-IFRS)에 따라 작성한 연결재무제표 기준 자기자본에 공시사유 발생일까지 당해 사업연도의 자본금 및 자본잉여금의 증감액을 반영한 수치입니다. 2. 상기 '3. 취득후 소유주식수 및 지분비율'은 본 거래로 취득할 주식수 및 지분율이며, 당사는 본 거래에 따라 발행회사의 지배력을 취득합니다. 3. 상기 '6. 취득예정일자'는 거래 완결(인수대금 납입 완료일) 예정일 입니다. 4. 발행회사는 2026년도 신설법인으로 요약 재무상황 기재를 생략합니다. | |||
[Issuer's Summary Financial Position]
(Unit: KRW m)
| Category | Total Assets | Total Liabilities | Total Equity | Paid-in Capital | Revenue | Net Income |
| Current year | - | - | - | - | - | - |
| Prior Year | - | - | - | - | - | - |
| Two Years Prior | - | - | - | - | - | - |
[Counterparty Information]
| 1. Personal Information | |||
| - General Information | |||
| Name (Entity Name) | Nationality | Address (Head Office) [Town/District Level Only] | Date of Birth (Business Registration No., etc.) |
| 한재익 | Republic of Korea | 서울특별시 서초구 서초동 | 710930 |
| Occupation (business) | (주)오션엔지니어링 대표이사 | ||
| - Largest Shareholder, CEO, Representative Executive Officer and Financial Condition (if counterparty is a corporation) | |||
| Category | Name | Number of Shares | Ownership (%) |
| Largest Shareholder | - | - | - |
| CEO | - | - | - |
| (Unit: KRW m) | |||
| Relevant fiscal year | - | Fiscal year-end | - |
| Total Assets | - | Paid-in Capital | - |
| Total Liabilities | - | Revenue | - |
| Total Equity | - | Net income (loss) | - |
| External Auditor | - | Business suspended | No |
| Audit Opinion | - | Business closed | No |
| 2. Relationship with Counterparty | |||
| 1. Relationship between Company and Counterparty | - | ||
| 2. Relationship between Company's Largest Shareholder/Officers and Counterparty | Name | Relationship with Counterparty | |
| - | - | - | |
| 3. Transactions in Past 3 Years (excl. Ordinary Transactions) | |||
| Category | Transaction Details | ||
| Current year | 2026.06.19 (주)나이스헬스디바이스코퍼레이션 주식양수도 380,000주 거래금액: 1,920,252,055원 | ||
| Prior Year | - | ||
| Two Years Prior | - | ||